Loading…

Obesity and cardiovascular disease: revisiting an old relationship

A wealth of clinical and epidemiological evidence has linked obesity to a broad spectrum of cardiovascular diseases (CVD) including coronary heart disease, heart failure, hypertension, stroke, atrial fibrillation and sudden cardiac death. Obesity can increase CVD morbidity and mortality directly and...

Full description

Saved in:
Bibliographic Details
Published in:Metabolism, clinical and experimental clinical and experimental, 2019-03, Vol.92, p.98-107
Main Authors: Koliaki, Chrysi, Liatis, Stavros, Kokkinos, Alexander
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c365t-361d00b3d9c00e18c348d20c4a329b51a2e4908106e11df4ef4595f018ac30ba3
cites cdi_FETCH-LOGICAL-c365t-361d00b3d9c00e18c348d20c4a329b51a2e4908106e11df4ef4595f018ac30ba3
container_end_page 107
container_issue
container_start_page 98
container_title Metabolism, clinical and experimental
container_volume 92
creator Koliaki, Chrysi
Liatis, Stavros
Kokkinos, Alexander
description A wealth of clinical and epidemiological evidence has linked obesity to a broad spectrum of cardiovascular diseases (CVD) including coronary heart disease, heart failure, hypertension, stroke, atrial fibrillation and sudden cardiac death. Obesity can increase CVD morbidity and mortality directly and indirectly. Direct effects are mediated by obesity-induced structural and functional adaptations of the cardiovascular system to accommodate excess body weight, as well as by adipokine effects on inflammation and vascular homeostasis. Indirect effects are mediated by co-existing CVD risk factors such as insulin resistance, hyperglycemia, hypertension and dyslipidemia. Adipose tissue (AT) quality and functionality are more relevant aspects for cardiometabolic risk than its total amount. The consequences of maladaptive AT expansion in obesity are local and systemic: the local include inflammation, hypoxia, dysregulated adipokine secretion and impaired mitochondrial function; the systemic comprise insulin resistance, abnormal glucose/lipid metabolism, hypertension, a pro-inflammatory and pro-thrombotic state and endothelial dysfunction, all of which provide linking mechanisms for the association between obesity and CVD. The present narrative review summarizes the major pathophysiological links between obesity and CVD (traditional and novel concepts), analyses the heterogeneity of obesity-related cardiometabolic consequences, and provides an overview of the cardiovascular impact of weight loss interventions. •Obesity is closely linked to CVD•This relationship is direct and indirect•Adipose tissue localization and metabolism play a crucial role•Weight loss confers important risk reduction
doi_str_mv 10.1016/j.metabol.2018.10.011
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2130801574</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0026049518302294</els_id><sourcerecordid>2130801574</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-361d00b3d9c00e18c348d20c4a329b51a2e4908106e11df4ef4595f018ac30ba3</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EglL4BFCWbBJm4jgPNggqXlKlbmBtOfYEXKVJsZNK_XtctbBlNdLVuTOaw9gVQoKA-e0yWdGg6r5NUsAyZAkgHrEJCp7GZQ5wzCYAaR5DVokzdu79EgCKosxP2RkHXlW8EBP2uKjJ22Ebqc5EWjlj-43yemyVi4z1pDzdRY42NkC2-wxY1LcmJK0abN_5L7u-YCeNaj1dHuaUfTw_vc9e4_ni5W32MI81z8UQ8xwNQM1NpQEIS82z0qSgM8XTqhaoUsoqKBFyQjRNRk0mKtGE55TmUCs-ZTf7vWvXf4_kB7myXlPbqo760csUOZSAosgCKvaodr33jhq5dnal3FYiyJ0-uZQHfXKnbxcHfaF3fTgx1isyf61fXwG43wMUHt1YctJrS50mYx3pQZre_nPiB31vgwE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2130801574</pqid></control><display><type>article</type><title>Obesity and cardiovascular disease: revisiting an old relationship</title><source>ScienceDirect Freedom Collection</source><creator>Koliaki, Chrysi ; Liatis, Stavros ; Kokkinos, Alexander</creator><creatorcontrib>Koliaki, Chrysi ; Liatis, Stavros ; Kokkinos, Alexander</creatorcontrib><description>A wealth of clinical and epidemiological evidence has linked obesity to a broad spectrum of cardiovascular diseases (CVD) including coronary heart disease, heart failure, hypertension, stroke, atrial fibrillation and sudden cardiac death. Obesity can increase CVD morbidity and mortality directly and indirectly. Direct effects are mediated by obesity-induced structural and functional adaptations of the cardiovascular system to accommodate excess body weight, as well as by adipokine effects on inflammation and vascular homeostasis. Indirect effects are mediated by co-existing CVD risk factors such as insulin resistance, hyperglycemia, hypertension and dyslipidemia. Adipose tissue (AT) quality and functionality are more relevant aspects for cardiometabolic risk than its total amount. The consequences of maladaptive AT expansion in obesity are local and systemic: the local include inflammation, hypoxia, dysregulated adipokine secretion and impaired mitochondrial function; the systemic comprise insulin resistance, abnormal glucose/lipid metabolism, hypertension, a pro-inflammatory and pro-thrombotic state and endothelial dysfunction, all of which provide linking mechanisms for the association between obesity and CVD. The present narrative review summarizes the major pathophysiological links between obesity and CVD (traditional and novel concepts), analyses the heterogeneity of obesity-related cardiometabolic consequences, and provides an overview of the cardiovascular impact of weight loss interventions. •Obesity is closely linked to CVD•This relationship is direct and indirect•Adipose tissue localization and metabolism play a crucial role•Weight loss confers important risk reduction</description><identifier>ISSN: 0026-0495</identifier><identifier>EISSN: 1532-8600</identifier><identifier>DOI: 10.1016/j.metabol.2018.10.011</identifier><identifier>PMID: 30399375</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Abnormal fat depots ; Adipokines ; Cardiovascular disease ; Fat distribution ; Insulin resistance ; Obesity</subject><ispartof>Metabolism, clinical and experimental, 2019-03, Vol.92, p.98-107</ispartof><rights>2018 Elsevier Inc.</rights><rights>Copyright © 2018 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-361d00b3d9c00e18c348d20c4a329b51a2e4908106e11df4ef4595f018ac30ba3</citedby><cites>FETCH-LOGICAL-c365t-361d00b3d9c00e18c348d20c4a329b51a2e4908106e11df4ef4595f018ac30ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30399375$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koliaki, Chrysi</creatorcontrib><creatorcontrib>Liatis, Stavros</creatorcontrib><creatorcontrib>Kokkinos, Alexander</creatorcontrib><title>Obesity and cardiovascular disease: revisiting an old relationship</title><title>Metabolism, clinical and experimental</title><addtitle>Metabolism</addtitle><description>A wealth of clinical and epidemiological evidence has linked obesity to a broad spectrum of cardiovascular diseases (CVD) including coronary heart disease, heart failure, hypertension, stroke, atrial fibrillation and sudden cardiac death. Obesity can increase CVD morbidity and mortality directly and indirectly. Direct effects are mediated by obesity-induced structural and functional adaptations of the cardiovascular system to accommodate excess body weight, as well as by adipokine effects on inflammation and vascular homeostasis. Indirect effects are mediated by co-existing CVD risk factors such as insulin resistance, hyperglycemia, hypertension and dyslipidemia. Adipose tissue (AT) quality and functionality are more relevant aspects for cardiometabolic risk than its total amount. The consequences of maladaptive AT expansion in obesity are local and systemic: the local include inflammation, hypoxia, dysregulated adipokine secretion and impaired mitochondrial function; the systemic comprise insulin resistance, abnormal glucose/lipid metabolism, hypertension, a pro-inflammatory and pro-thrombotic state and endothelial dysfunction, all of which provide linking mechanisms for the association between obesity and CVD. The present narrative review summarizes the major pathophysiological links between obesity and CVD (traditional and novel concepts), analyses the heterogeneity of obesity-related cardiometabolic consequences, and provides an overview of the cardiovascular impact of weight loss interventions. •Obesity is closely linked to CVD•This relationship is direct and indirect•Adipose tissue localization and metabolism play a crucial role•Weight loss confers important risk reduction</description><subject>Abnormal fat depots</subject><subject>Adipokines</subject><subject>Cardiovascular disease</subject><subject>Fat distribution</subject><subject>Insulin resistance</subject><subject>Obesity</subject><issn>0026-0495</issn><issn>1532-8600</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqFkMtOwzAQRS0EglL4BFCWbBJm4jgPNggqXlKlbmBtOfYEXKVJsZNK_XtctbBlNdLVuTOaw9gVQoKA-e0yWdGg6r5NUsAyZAkgHrEJCp7GZQ5wzCYAaR5DVokzdu79EgCKosxP2RkHXlW8EBP2uKjJ22Ebqc5EWjlj-43yemyVi4z1pDzdRY42NkC2-wxY1LcmJK0abN_5L7u-YCeNaj1dHuaUfTw_vc9e4_ni5W32MI81z8UQ8xwNQM1NpQEIS82z0qSgM8XTqhaoUsoqKBFyQjRNRk0mKtGE55TmUCs-ZTf7vWvXf4_kB7myXlPbqo760csUOZSAosgCKvaodr33jhq5dnal3FYiyJ0-uZQHfXKnbxcHfaF3fTgx1isyf61fXwG43wMUHt1YctJrS50mYx3pQZre_nPiB31vgwE</recordid><startdate>201903</startdate><enddate>201903</enddate><creator>Koliaki, Chrysi</creator><creator>Liatis, Stavros</creator><creator>Kokkinos, Alexander</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201903</creationdate><title>Obesity and cardiovascular disease: revisiting an old relationship</title><author>Koliaki, Chrysi ; Liatis, Stavros ; Kokkinos, Alexander</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-361d00b3d9c00e18c348d20c4a329b51a2e4908106e11df4ef4595f018ac30ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Abnormal fat depots</topic><topic>Adipokines</topic><topic>Cardiovascular disease</topic><topic>Fat distribution</topic><topic>Insulin resistance</topic><topic>Obesity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koliaki, Chrysi</creatorcontrib><creatorcontrib>Liatis, Stavros</creatorcontrib><creatorcontrib>Kokkinos, Alexander</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Metabolism, clinical and experimental</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koliaki, Chrysi</au><au>Liatis, Stavros</au><au>Kokkinos, Alexander</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Obesity and cardiovascular disease: revisiting an old relationship</atitle><jtitle>Metabolism, clinical and experimental</jtitle><addtitle>Metabolism</addtitle><date>2019-03</date><risdate>2019</risdate><volume>92</volume><spage>98</spage><epage>107</epage><pages>98-107</pages><issn>0026-0495</issn><eissn>1532-8600</eissn><abstract>A wealth of clinical and epidemiological evidence has linked obesity to a broad spectrum of cardiovascular diseases (CVD) including coronary heart disease, heart failure, hypertension, stroke, atrial fibrillation and sudden cardiac death. Obesity can increase CVD morbidity and mortality directly and indirectly. Direct effects are mediated by obesity-induced structural and functional adaptations of the cardiovascular system to accommodate excess body weight, as well as by adipokine effects on inflammation and vascular homeostasis. Indirect effects are mediated by co-existing CVD risk factors such as insulin resistance, hyperglycemia, hypertension and dyslipidemia. Adipose tissue (AT) quality and functionality are more relevant aspects for cardiometabolic risk than its total amount. The consequences of maladaptive AT expansion in obesity are local and systemic: the local include inflammation, hypoxia, dysregulated adipokine secretion and impaired mitochondrial function; the systemic comprise insulin resistance, abnormal glucose/lipid metabolism, hypertension, a pro-inflammatory and pro-thrombotic state and endothelial dysfunction, all of which provide linking mechanisms for the association between obesity and CVD. The present narrative review summarizes the major pathophysiological links between obesity and CVD (traditional and novel concepts), analyses the heterogeneity of obesity-related cardiometabolic consequences, and provides an overview of the cardiovascular impact of weight loss interventions. •Obesity is closely linked to CVD•This relationship is direct and indirect•Adipose tissue localization and metabolism play a crucial role•Weight loss confers important risk reduction</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>30399375</pmid><doi>10.1016/j.metabol.2018.10.011</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0026-0495
ispartof Metabolism, clinical and experimental, 2019-03, Vol.92, p.98-107
issn 0026-0495
1532-8600
language eng
recordid cdi_proquest_miscellaneous_2130801574
source ScienceDirect Freedom Collection
subjects Abnormal fat depots
Adipokines
Cardiovascular disease
Fat distribution
Insulin resistance
Obesity
title Obesity and cardiovascular disease: revisiting an old relationship
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T19%3A07%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Obesity%20and%20cardiovascular%20disease:%20revisiting%20an%20old%20relationship&rft.jtitle=Metabolism,%20clinical%20and%20experimental&rft.au=Koliaki,%20Chrysi&rft.date=2019-03&rft.volume=92&rft.spage=98&rft.epage=107&rft.pages=98-107&rft.issn=0026-0495&rft.eissn=1532-8600&rft_id=info:doi/10.1016/j.metabol.2018.10.011&rft_dat=%3Cproquest_cross%3E2130801574%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c365t-361d00b3d9c00e18c348d20c4a329b51a2e4908106e11df4ef4595f018ac30ba3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2130801574&rft_id=info:pmid/30399375&rfr_iscdi=true